Segment Information: Our three reportable segments include: (1) Lithium; (2) Bromine Specialties; and (3) Catalysts. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This business structure aligns with the markets and customers we serve through each of the segments. This structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Companys chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. The All Other category includes only the fine chemistry services business that does not fit into any of our core businesses. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (Non-operating pension and OPEB items) are included in Corporate. Segment data includes inter-segment transfers of raw materials at cost and allocations for certain corporate costs. The Companys chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Companys business segments and to allocate resources. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items in a balanced manner and on a segment basis. These non-recurring or unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 (In thousands) (In thousands) Net sales: Lithium $ 283,722 $ 324,758 $ 520,540 $ 616,644 Bromine Specialties 232,779 255,433 464,371 504,485 Catalysts 197,053 266,301 404,260 517,949 All Other 50,495 38,560 113,723 78,038 Total net sales $ 764,049 $ 885,052 $ 1,502,894 $ 1,717,116 Adjusted EBITDA: Lithium $ 94,536 $ 141,779 $ 173,173 $ 257,395 Bromine Specialties 73,041 81,332 156,303 159,929 Catalysts 22,777 66,875 70,247 126,946 All Other 18,598 11,240 41,422 18,483 Corporate (23,759) (39,326) (59,587) (74,986) Total adjusted EBITDA $ 185,193 $ 261,900 $ 381,558 $ 487,767 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Specialties Catalysts Reportable Segments Total All Other Corporate Consolidated Total Three months ended June 30, 2020 Net income (loss) attributable to Albemarle Corporation $ 66,038 $ 60,692 $ 10,702 $ 137,432 $ 16,425 $ (68,233) $ 85,624 Depreciation and amortization 28,498 12,349 12,075 52,922 2,173 2,746 57,841 Restructuring and other (a)      6,733 6,733 Acquisition and integration related costs (b)      5,470 5,470 Interest and financing expenses      17,852 17,852 Income tax expense      15,431 15,431 Non-operating pension and OPEB items      (2,895) (2,895) Other (c)      (863) (863) Adjusted EBITDA $ 94,536 $ 73,041 $ 22,777 $ 190,354 $ 18,598 $ (23,759) $ 185,193 Three months ended June 30, 2019 Net income (loss) attributable to Albemarle Corporation $ 117,303 $ 69,616 $ 54,124 $ 241,043 $ 9,118 $ (95,963) $ 154,198 Depreciation and amortization 24,365 11,716 12,751 48,832 2,122 1,994 52,948 Restructuring and other (a)      4,760 4,760 Acquisition and integration related costs (b)      4,990 4,990 Interest and financing expenses      11,601 11,601 Income tax expense      30,411 30,411 Non-operating pension and OPEB items      (676) (676) Other (d) 111   111  3,557 3,668 Adjusted EBITDA $ 141,779 $ 81,332 $ 66,875 $ 289,986 $ 11,240 $ (39,326) $ 261,900 Six months ended June 30, 2020 Net income (loss) attributable to Albemarle Corporation $ 119,278 $ 132,357 $ 45,594 $ 297,229 $ 37,271 $ (141,672) $ 192,828 Depreciation and amortization 53,895 23,946 24,653 102,494 4,151 4,890 111,535 Restructuring and other (a)      8,580 8,580 Acquisition and integration related costs (b)      8,426 8,426 Interest and financing expenses      34,737 34,737 Income tax expense      33,873 33,873 Non-operating pension and OPEB items      (5,803) (5,803) Other (c)      (2,618) (2,618) Adjusted EBITDA $ 173,173 $ 156,303 $ 70,247 $ 399,723 $ 41,422 $ (59,587) $ 381,558 Six months ended June 30, 2019 Net income (loss) attributable to Albemarle Corporation $ 210,472 $ 137,096 $ 101,983 $ 449,551 $ 14,324 $ (176,108) $ 287,767 Depreciation and amortization 46,457 22,833 24,963 94,253 4,159 3,819 102,231 Restructuring and other (a)      5,290 5,290 Acquisition and integration related costs (b)      10,274 10,274 Gain on sale of property (e)      (11,079) (11,079) Interest and financing expenses      24,187 24,187 Income tax expense      67,925 67,925 Non-operating pension and OPEB items      (1,259) (1,259) Other (d) 466   466  1,965 2,431 Adjusted EBITDA $ 257,395 $ 159,929 $ 126,946 $ 544,270 $ 18,483 $ (74,986) $ 487,767 (a) Severance expenses as part of a business reorganization plan, primarily within our Lithium business in Germany, as well in our Bromine Specialties business in 2020. During the three months ended June 30, 2020, we recorded expenses of $6.7 million in Selling, general and administrative expenses. During the six months ended June 30, 2020, we recorded expenses of $0.7 million in Cost of goods sold, $8.2 million in Selling, general and administrative expenses and a $0.3 million gain in Net income attributable to noncontrolling interests for the portion of severance expense allocated to our Jordanian joint venture partner. The balance of unpaid severance is recorded in Accrued expenses and is expected to primarily be paid through the first quarter of 2021. During the three and six months ended June 30, 2019, severance expenses of $4.8 million and $5.3 million, respectively, were recorded in Selling, general and administrative expenses as part of a business reorganization plan primarily in Catalysts, Lithium and Corporate. (b) Costs related to the acquisition, integration and potential divestitures for various significant projects, recorded in Selling, general and administrative expenses. (c) Included amounts for the three months ended June 30, 2020 recorded in:  Other (expenses) income, net - $0.9 million net gain primarily relating to the sale of idle properties in Germany. Included amounts for the six months ended June 30, 2020 recorded in:  Other (expenses) income, net - $2.7 million gain resulting from the settlement of a legal matter related to a business sold and $0.8 million net gain primarily relating to the sale of idle properties in Germany, partially offset by a $0.8 million loss resulting from the adjustment of indemnifications related to previously disposed businesses. (d) Included amounts for the three months ended June 30, 2019 recorded in:  Cost of goods sold - $0.1 million related to non-routine labor and compensation related costs in Chile that were outside normal compensation arrangements.  Selling, general and administrative expenses - $1.0 million of shortfall contributions for our multiemployer plan financial improvement plan.  Other (expenses) income, net - $2.5 million of a net loss primarily resulting from the adjustment of indemnifications related to previously disposed businesses. Included amounts for the six months ended June 30, 2019 recorded in:  Cost of goods sold - $0.5 million related to non-routine labor and compensation related costs in Chile that were outside normal compensation arrangements.  Selling, general and administrative expenses - $1.0 million of shortfall contributions for our multiemployer plan financial improvement plan.  Other (expenses) income, net - $0.9 million of a net loss primarily resulting from the adjustment of indemnifications and other liabilities related to previously disposed businesses. (e) Gain recorded in Other (expenses) income, net related to the sale of land in Pasadena, Texas not used as part of our operations.